FedEx Launches Dedicated 'Life Sciences' Division for Healthcare Logistics

Establishment of a Dedicated Division for Pharmaceuticals and Biotechnology
Nick Zenari Appointed as President of the Division
Custom Infrastructure Including AI-Based Monitoring

FedEx, the global logistics company, is setting its sights on the advanced medical cargo transportation market, including pharmaceuticals and biotechnology.

FedEx Life Sciences. FedEx

On July 22, FedEx Corporation (hereafter FedEx) announced the launch of a dedicated organization, "FedEx Life Sciences," specializing in freight transportation for the healthcare sector.

The establishment of this new unit aims to enhance precision and visibility, taking into account the unique characteristics of healthcare cargo that are sensitive to temperature and time, such as pharmaceuticals, biopharmaceuticals, clinical trial materials, and medical devices. FedEx Life Sciences plans to support the pharmaceutical and healthcare industries by combining its global logistics network with this dedicated team and advanced monitoring capabilities.

With the launch of this division, FedEx appointed Nick Zenari as President of Healthcare and Life Sciences. Since joining the company in 1992, President Nick Zenari has been leading global supply chain solutions for more than 30 years. Since 2024, he has overseen the healthcare division and has contributed to growing the company’s global healthcare revenue to approximately USD 10 billion.

Bri Carere, Executive Vice President and Chief Customer Officer at FedEx, stated, "Healthcare cargo transportation that can determine lives requires an intelligent and highly specialized network that goes beyond typical logistics services and is designed to meet medical needs. Every piece of healthcare cargo handled by FedEx has the potential to support researchers, medical professionals, and, most importantly, patients awaiting treatment." She added, "FedEx Life Sciences is developing an even more intelligent and resilient supply chain to address these vital needs by combining FedEx’s global network, advanced monitoring technology, and specialized expertise. Under President Nick Zenari's leadership, the dedicated team will support customers so that essential shipments for patients can be delivered with the utmost speed, reliability, and precision."

FedEx is also expanding its infrastructure to enhance its competitiveness in healthcare logistics. In 2025, it acquired the "CEIV Pharma" corporate certification for pharmaceutical air transport quality from the International Air Transport Association (IATA). FedEx currently operates six life sciences centers worldwide. The company established a direct route linking Indianapolis in the United States and Dublin in Ireland, strengthening its transatlantic connectivity. FedEx also introduced "FedEx Surround," a machine learning-based monitoring service, to secure visibility throughout the shipping process and prevent disruptions in advance.

Nick Zenari, President of Healthcare and Life Sciences at FedEx, stated, "As healthcare supply chains grow more complex, their importance is directly tied to every individual’s life. FedEx Life Sciences provides customers with enhanced specialized teams, a reinforced collaboration system, and specialized expertise to ensure they can confidently transport critical healthcare cargo."

This content was produced with the assistance of AI translation services.